|
CP110 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.870600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.139800E-01 |
| Normal-vs-Stage2 |
5.326600E-01 |
| Normal-vs-Stage3 |
9.702000E-01 |
| Normal-vs-Stage4 |
2.771400E-01 |
| Stage1-vs-Stage2 |
9.399400E-01 |
| Stage1-vs-Stage3 |
4.351800E-01 |
| Stage1-vs-Stage4 |
6.149400E-01 |
| Stage2-vs-Stage3 |
6.298000E-01 |
| Stage2-vs-Stage4 |
6.036800E-01 |
| Stage3-vs-Stage4 |
4.060000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.665800E-01 |
| Normal-vs-AfricanAmerican |
3.581200E-01 |
| Normal-vs-Asian |
8.424800E-01 |
| Caucasian-vs-AfricanAmerican |
5.584000E-01 |
| Caucasian-vs-Asian |
9.471400E-01 |
| AfricanAmerican-vs-Asian |
8.831400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.594830E-01 |
| Normal-vs-Female |
1.813750E-01 |
| Male-vs-Female |
1.383770E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.877400E-01 |
| Normal-vs-Extreme_Weight |
2.491500E-02 |
| Normal-vs-Obese |
7.052400E-01 |
| Normal-vs-Extreme_Obese |
2.386600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.599800E-01 |
| Normal_Weight-vs-Obese |
2.331600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.264000E-01 |
| Extreme_Weight-vs-Obese |
2.660000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.821800E-01 |
| Obese-vs-Extreme_Obese |
2.140800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.015000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.181000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.213200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.175900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.030600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.011200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.649950E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.217040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.001700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.017910E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.442400E-01 |
| Normal-VS-Type2 PRCC |
5.081500E-03 |
| Normal-VS-KIRP CIMP |
3.594200E-01 |
| Normal-VS-Unclassified PRCC |
3.113800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.901500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.722200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.607600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.341510E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.363890E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.574800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.721800E-02 |
| Normal-vs-N1 |
3.671000E-01 |
| Normal-vs-N2 |
5.147000E-01 |
| N0-vs-N1 |
7.298000E-02 |
| N0-vs-N2 |
8.230800E-01 |
| N1-vs-N2 |
3.573400E-01 |
|
|
